Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02431494 · ClinicalTrials.gov registry record · NA
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
A NA study, sponsored by Nova Southeastern University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02431494 is a NA study that was terminated before completion, run by Nova Southeastern University. The registered enrollment target is 4 participants.
The verdict
NCT02431494, a NA study, was terminated before completion, sponsored by Nova Southeastern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Acne vulgaris is a multifactorial, highly prevalent dermatologic condition that results in visible lesions that can be quite disfiguring. Consequently, individuals with acne often suffer from a wide range of psychological manifestations. Although there is consensus that combination therapy is most effective in treating acne, researchers are constantly striving to develop new treatment. Microcurrent therapy (MCT) is a non-invasive modality that has successfully been used to promote wound healing and has been routinely used in aesthetics. Use of MCT alone or in combination with current successful treatment such as blue light phototherapy (BLP), may hold promise for acne treatment. The investigators propose to conduct a small randomized control trial to determine the safety and preliminary efficacy of a novel combination therapy to treat acne vulgaris. The investigators will recruit up to 60 males and females and randomly assign them to one of 3 arms: 1) BLP; 2) MCT; and combination therapy (BLP and MCT). The investigators will assess physiological parameters (number of acne lesions, amount of sebum produced, degree of acne severity) and psychosocial factors (dermatologic quality of life, social anxiety, depressive symptomatology, self-esteem). Participants will complete a baseline assessment prior to initiating treatment and a follow-up assessment at 4 weeks post termination of treatment. The investigators will conduct intermediary assessments at weeks 3 and 5 and 1 week post termination of the treatment. The investigators will use measures of central tendency to describe the sample and repeated measures analysis of variance to compute the main and interaction effects.
Interventions
- DEVICE Blue light phototherapy
- DEVICE Microcurrent therapy
- DEVICE Combination of BLP and Microcurrent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-10-30 |
| Est. Completion | 2017-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02431494
The ClinicalTrials.gov registry entry for NCT02431494 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blue light phototherapy is the first listed.
NCT02431494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02431494 about?
NCT02431494 is a clinical study titled "Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris". Acne vulgaris is a multifactorial, highly prevalent dermatologic condition that results in visible lesions that can be quite disfiguring. Consequently, individuals with acne often suffer from a wide range of psychological manifestations. Although there is consensus that combination therapy is most e...
What is the current status of trial NCT02431494?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-10-30. Estimated completion is 2017-05-12.
What interventions are being tested in trial NCT02431494?
The interventions under investigation include: Blue light phototherapy (DEVICE), Microcurrent therapy (DEVICE), Combination of BLP and Microcurrent (DEVICE).
Who is sponsoring clinical trial NCT02431494?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.